(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are ELECTROMAGNET GEO, BIOSENIC, and BENEVOLENTAI.

Financial Asset	Price	Change	Updated (EST)
ELECTROMAGNET GEO (EMGS.OL)	2.65	32.5%	2023-12-28 12:25:37
BIOSENIC (BIOS.BR)	0.07	32.06%	2023-12-28 12:05:11
BENEVOLENTAI (BAI.AS)	2.18	30.54%	2023-12-28 12:00:53
BORGESTAD (BOR.OL)	0.35	15%	2023-12-28 12:25:03
CLARANOVA (CLA.PA)	2.00	11.73%	2023-12-28 13:01:13
ALUMEXX N.V. (ALX.AS)	1.25	11.61%	2023-12-28 12:00:26
NANOBIOTIX (NANO.PA)	6.80	8.97%	2023-12-28 13:20:33
ATENOR (ATEB.BR)	7.42	7.85%	2023-12-28 12:04:51
OREGE (OREGE.PA)	0.45	7.75%	2023-12-28 13:21:00
METABOLIC EXPLORER (METEX.PA)	0.40	7.21%	2023-12-28 13:20:22

The three biggest losers today are SODITECH, AKER HORIZONS, and AFFLUENT MEDICAL.

Financial Asset	Price	Change	Updated (EST)
SODITECH (SEC.PA)	1.01	-19.84%	2023-12-28 13:22:57
AKER HORIZONS (AKH.OL)	4.46	-9.24%	2023-12-28 12:24:22
AFFLUENT MEDICAL (AFME.PA)	1.82	-8.31%	2023-12-28 12:45:47
THUNDERBIRD (TBIRD.AS)	0.07	-8.28%	2023-12-28 12:04:01
KEYWARE TECH. (KEYW.BR)	0.90	-5.76%	2023-12-28 12:20:31
ATLANTIC SAPPHIRE (ASA.OL)	1.63	-5.45%	2023-12-28 12:24:40
NORTHERN DRILLING (NODL.OL)	1.05	-4.98%	2023-12-28 12:41:38
POXEL (POXEL.PA)	0.61	-4.84%	2023-12-28 13:21:33
HAVILA SHIPPING (HAVI.OL)	5.35	-4.12%	2023-12-28 12:40:27
ARRIBATEC GROUP (ARR.OL)	4.55	-4.01%	2023-12-28 12:24:35

Winners today

1. ELECTROMAGNET GEO (EMGS.OL)

32.5% Price Change

Electromagnetic Geoservices ASA, together with its subsidiaries, provides electromagnetic (EM) surveying services to the offshore oil and gas exploration industry. It is involved in the planning, acquisition, processing, modelling, interpretation, and integration of EM data. The company uses its patented EM survey method to find hydrocarbons in offshore reservoirs. It engages in the provision of controlled-source EM surveying and magneto telluric surveying; imaging and interpretation; rental of software and cluster; and training services. The company has operations in Europe, the Middle East, Africa, Norway, North and South America, Asia, and the Pacific Ocean. Electromagnetic Geoservices ASA was incorporated in 2002 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ELECTROMAGNET GEO rising 32.5% to €2.65 on Thursday, after two successive sessions in a row of gains. Oslo Børs Benchmark Index_GI slid 0.21% to €1,304.40, after two sequential sessions in a row of gains, on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, ELECTROMAGNET GEO has a trailing twelve months EPS of kr0.31.

PE Ratio

ELECTROMAGNET GEO has a trailing twelve months price to earnings ratio of 8.55. Meaning, the purchaser of the share is investing kr8.55 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 145.52%.

Volume

Today’s last reported volume for ELECTROMAGNET GEO is 7111760 which is 883.38% above its average volume of 723194.

Sales Growth

ELECTROMAGNET GEO’s sales growth is negative 25.8% for the present quarter and negative 40.5% for the next.

Revenue Growth

Year-on-year quarterly revenue growth declined by 97.2%, now sitting on 27.05M for the twelve trailing months.

More news about ELECTROMAGNET GEO.

2. BIOSENIC (BIOS.BR)

32.06% Price Change

BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures' and ArsciCor, which is in Phase III in GvHD is being prepared with an oral treatment. BioSenic S.A. is based in Mont-Saint-Guibert, Belgium.

BEL 20 ended the session with BIOSENIC jumping 32.06% to €0.07 on Thursday while BEL 20 fell 0.19% to €3,703.95.

Earnings Per Share

As for profitability, BIOSENIC has a trailing twelve months EPS of €7.53.

PE Ratio

BIOSENIC has a trailing twelve months price to earnings ratio of 0.01. Meaning, the purchaser of the share is investing €0.01 for every euro of annual earnings.

Volume

Today’s last reported volume for BIOSENIC is 2020860 which is 270.29% above its average volume of 545739.

Volatility

BIOSENIC’s last week, last month’s, and last quarter’s current intraday variation average was 0.97%, 1.77%, and 6.05%.

BIOSENIC’s highest amplitude of average volatility was 0.97% (last week), 6.80% (last month), and 6.05% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, BIOSENIC’s stock is considered to be oversold (<=20).

More news about BIOSENIC.

3. BENEVOLENTAI (BAI.AS)

30.54% Price Change

BenevolentAI S.A. operates as a clinical-stage AI-enabled drug discovery and development company. Its BenevolentAI platform powers in-house drug pipeline of drug programs. The company's therapeutic areas, include atopic dermatitis, ulcerative colitis, amyotrophic lateral sclerosis, glioblastoma multiforme, inflammatory bowel disease, antiviral, oncology, parkinson's disease, nonalcoholic steatohepatitis, fibrosis, inflammation, chronic kidney disease, and idiopathic pulmonary fibrosis. It has a collaboration with AstraZeneca to enhance understanding of complex disease biology and identify new targets. The company was founded in 2013 and is headquartered in London, United Kingdom.

AEX-Index ended the session with BENEVOLENTAI jumping 30.54% to €2.18 on Thursday, after three successive sessions in a row of gains. AEX-Index rose 0.03% to €787.04, following the last session’s upward trend on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, BENEVOLENTAI has a trailing twelve months EPS of €-0.47.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -40.97%.

More news about BENEVOLENTAI.

4. BORGESTAD (BOR.OL)

15% Price Change

Borgestad ASA develops, manufactures, distributes, and installs refractory products in Norway. The company also develops and manages real estate properties. Its properties include Agora Bytom, a shopping center with a gross area of 52,000 square meters and a rental area of approximately 30,000 square meters, as well as a parking garage with 820 parking lots in Poland. Borgestad ASA was founded in 1904 and is headquartered in Skien, Norway.

Oslo Børs Benchmark Index_GI ended the session with BORGESTAD jumping 15% to €0.35 on Thursday, following the last session’s downward trend. Oslo Børs Benchmark Index_GI slid 0.21% to €1,304.40, after two successive sessions in a row of gains, on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, BORGESTAD has a trailing twelve months EPS of kr-0.3.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.11%.

Moving Average

BORGESTAD’s value is way under its 50-day moving average of kr1.50 and way under its 200-day moving average of kr1.46.

Revenue Growth

Year-on-year quarterly revenue growth grew by 31.8%, now sitting on 1.02B for the twelve trailing months.

Earnings Before Interest, Taxes, Depreciation, and Amortization

BORGESTAD’s EBITDA is 122.4.

Yearly Top and Bottom Value

BORGESTAD’s stock is valued at kr0.35 at 21:40 EST, way under its 52-week low of kr1.23.

More news about BORGESTAD.

5. CLARANOVA (CLA.PA)

11.73% Price Change

Claranova SE, a technology company, engages in personalized e-commerce, software publishing, and internet of things (IoT) management in France, the United States, the United Kingdom, Germany, other European countries, and internationally. It operates in three segments: PlanetArt, Avanquest, and myDevices. The PlanetArt segment offers photos, frames, personalized books, and FreePrints mobile applications. The Avanquest segment provides antivirus, ad blocker, cleaning, and optimization tools under the Adaware brand; document management tools under the SodaPDF brand; and photo editor software and applications developed under the inPixio brand. The myDevices segment offers IoT solutions. Claranova SE was incorporated in 1984 and is headquartered in Courbevoie, France.

CAC 40 ended the session with CLARANOVA rising 11.73% to €2.00 on Thursday while CAC 40 fell 0.48% to €7,535.16.

Earnings Per Share

As for profitability, CLARANOVA has a trailing twelve months EPS of €-0.23.

Yearly Top and Bottom Value

CLARANOVA’s stock is valued at €2.00 at 21:40 EST, way below its 52-week high of €2.95 and way higher than its 52-week low of €1.23.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CLARANOVA’s stock is considered to be oversold (<=20).

Volatility

CLARANOVA’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.57%, a positive 1.42%, and a positive 2.77%.

CLARANOVA’s highest amplitude of average volatility was 1.79% (last week), 3.23% (last month), and 2.77% (last quarter).

More news about CLARANOVA.

6. ALUMEXX N.V. (ALX.AS)

11.61% Price Change

Alumexx N.V. manufactures and sells scaffoldings, stairs, ladders, accessories, and tools for indoor or outdoor use in the Netherlands and internationally. The company was formerly known as Phelix N.V. and changed its name to Alumexx N.V. in January 2018. Alumexx N.V. was founded in 1991 and is based in Etten-Leur, the Netherlands.

AEX-Index ended the session with ALUMEXX N.V. jumping 11.61% to €1.25 on Thursday, after three consecutive sessions in a row of gains. AEX-Index rose 0.03% to €787.04, following the last session’s upward trend on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, ALUMEXX N.V. has a trailing twelve months EPS of €0.12.

PE Ratio

ALUMEXX N.V. has a trailing twelve months price to earnings ratio of 10.42. Meaning, the purchaser of the share is investing €10.42 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 42.26%.

Moving Average

ALUMEXX N.V.’s worth is way higher than its 50-day moving average of €0.70 and way higher than its 200-day moving average of €0.67.

More news about ALUMEXX N.V..

7. NANOBIOTIX (NANO.PA)

8.97% Price Change

Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer. Nanobiotix S.A. has a partnership with Lian Oncology Limited to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. Nanobiotix S.A. was incorporated in 2003 and is headquartered in Paris, France.

CAC 40 ended the session with NANOBIOTIX rising 8.97% to €6.80 on Thursday while CAC 40 fell 0.48% to €7,535.16.

Earnings Per Share

As for profitability, NANOBIOTIX has a trailing twelve months EPS of €-1.68.

More news about NANOBIOTIX.

8. ATENOR (ATEB.BR)

7.85% Price Change

Atenor SA, a real estate development company, invests in large-scale real estate projects in Belgium, Luxembourg, the Netherlands, France, Germany, Portugal, Poland, Hungary, the United Kingdom, and Romania. The company develops real estate projects, such as offices and residential buildings. Atenor SA was founded in 1910 and is headquartered in La Hulpe, Belgium.

BEL 20 ended the session with ATENOR jumping 7.85% to €7.42 on Thursday, following the last session’s upward trend. BEL 20 dropped 0.19% to €3,703.95, after two consecutive sessions in a row of gains, on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, ATENOR has a trailing twelve months EPS of €-5.33.

Volume

Today’s last reported volume for ATENOR is 151005 which is 203.72% above its average volume of 49717.

More news about ATENOR.

9. OREGE (OREGE.PA)

7.75% Price Change

Orege Société Anonyme designs, develops, operates, manufactures, and markets municipal and industrial sludge, and effluents treatment solutions in France, the United States, Japan, Germany, and the United Kingdom. The company offers SLG solution for conditioning, treating, and recovering municipal and industrial sludge; SLG-F, a combination of SLG conditioning solution; and Flosep for sludge separation and thickening tool. It also provides after-sales, installation and commissioning, operator training, warranty extensions, maintenance, and process optimization packages. The company was incorporated in 2005 and is headquartered in Voisins-Le-Bretonneux, France. Orege Société Anonyme is a subsidiary of Eren Groupe SA.

CAC 40 ended the session with OREGE jumping 7.75% to €0.45 on Thursday, after two sequential sessions in a row of gains. CAC 40 fell 0.48% to €7,535.16, following the last session’s upward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, OREGE has a trailing twelve months EPS of €-0.15.

More news about OREGE.

10. METABOLIC EXPLORER (METEX.PA)

7.21% Price Change

METabolic EXplorer S.A., a biological chemistry company, engages in the development and industrialization of industrial fermentation processes as alternatives to petrochemical processes worldwide. The company also offers propanediol, butyric acid, butyric acid, glycolic acid, amino acid, and L-Valine. Its products are used in the formulation of cosmetics, textiles, polymer, animal nutrition, and health products or as intermediates for the synthesis of biomaterials. The company was incorporated in 1999 and is based in Saint-Beauzire, France.

CAC 40 ended the session with METABOLIC EXPLORER jumping 7.21% to €0.40 on Thursday, after two sequential sessions in a row of gains. CAC 40 dropped 0.48% to €7,535.16, following the last session’s upward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, METABOLIC EXPLORER has a trailing twelve months EPS of €-0.98.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -42.82%.

Yearly Top and Bottom Value

METABOLIC EXPLORER’s stock is valued at €0.40 at 21:40 EST, way under its 52-week high of €1.62 and way higher than its 52-week low of €0.22.

Volume

Today’s last reported volume for METABOLIC EXPLORER is 232760 which is 18.02% below its average volume of 283941.

More news about METABOLIC EXPLORER.

Losers Today

1. SODITECH (SEC.PA)

-19.84% Price Change

Soditech SA engages in the integration of mechanical, thermal, and electronic sub-assemblies in space, research, and defense fields in France. It designs structural sub-assemblies and integrates optical and thermal equipment, such as OSRs, SSMs, heaters, and heat pipes; designs and manufactures multi-layer insulation products; and designs, manufactures, and tests space harnesses on instruments or platforms. The company also provides calculation services, such as static, dynamic, thermal, and thermoelastic; designs assembly tools; and designs and produces super insulating multi-layer mattresses for ultra-vacuum areas. In addition, it develops, qualifies, manufactures, and tests embedded cabinets; and designs, assembles, and tests racks and test equipment racks. The company was formerly known as Soditech Ingenierie SA. Soditech SA was founded in 1990 and is headquartered in Aix-en-Provence, France.

CAC 40 ended the session with SODITECH dropping 19.84% to €1.01 on Thursday, after five sequential sessions in a row of losses. CAC 40 dropped 0.48% to €7,535.16, following the last session’s upward trend on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, SODITECH has a trailing twelve months EPS of €0.07.

PE Ratio

SODITECH has a trailing twelve months price to earnings ratio of 14.43. Meaning, the purchaser of the share is investing €14.43 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.54%.

Volume

Today’s last reported volume for SODITECH is 5135 which is 1845.08% above its average volume of 264.

More news about SODITECH.

2. AKER HORIZONS (AKH.OL)

-9.24% Price Change

Aker Horizons ASA, through its subsidiaries, develops and invests in a portfolio of companies in the renewable energy and green technology comprising private and public companies worldwide. It sources, develops, structures, builds, and operates wind and solar power assets; and develops, builds, owns, and operates clean hydrogen production at industrial scale. The company also provides products, technology, and solutions within the field of carbon capture, utilization, and storage. In addition, it offers products and services to the hydropower industry; designs and delivers superconducting systems; and produces silicon materials. The company was incorporated in 2020 and is headquartered in Lysaker, Norway. Aker Horizons ASA operates as a subsidiary of Aker Capital AS.

Oslo Børs Benchmark Index_GI ended the session with AKER HORIZONS falling 9.24% to €4.46 on Thursday while Oslo Børs Benchmark Index_GI fell 0.21% to €1,304.40.

Earnings Per Share

As for profitability, AKER HORIZONS has a trailing twelve months EPS of kr-9.91.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -81.14%.

Volume

Today’s last reported volume for AKER HORIZONS is 12497700 which is 88.24% above its average volume of 6639170.

Volatility

AKER HORIZONS’s last week, last month’s, and last quarter’s current intraday variation average was 2.94%, 1.29%, and 4.78%.

AKER HORIZONS’s highest amplitude of average volatility was 2.94% (last week), 4.73% (last month), and 4.78% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AKER HORIZONS’s stock is considered to be oversold (<=20).

More news about AKER HORIZONS.

3. AFFLUENT MEDICAL (AFME.PA)

-8.31% Price Change

Affluent Medical SA develops minimally invasive medical devices for the treatment of heart and vascular diseases in France. It develops Kardiozis technology for the treatment of abdominal aortic aneurysm; Kalios and Epygon implants to treat mitral insufficiency; and Artus implant, an implantable electro-mechanical artificial sphincter for the treatment of severe urinary incontinence in women and men. The company was founded in 2011 and is based in Aix-en-Provence, France.

CAC 40 ended the session with AFFLUENT MEDICAL sliding 8.31% to €1.82 on Thursday while CAC 40 dropped 0.48% to €7,535.16.

Earnings Per Share

As for profitability, AFFLUENT MEDICAL has a trailing twelve months EPS of €-0.65.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -39.36%.

Volatility

AFFLUENT MEDICAL’s last week, last month’s, and last quarter’s current intraday variation average was 4.55%, 2.95%, and 3.31%.

AFFLUENT MEDICAL’s highest amplitude of average volatility was 19.92% (last week), 5.72% (last month), and 3.31% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth declined by 25.8%, now sitting on 1.34M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AFFLUENT MEDICAL’s stock is considered to be overbought (>=80).

Volume

Today’s last reported volume for AFFLUENT MEDICAL is 19419 which is 150.6% above its average volume of 7749.

More news about AFFLUENT MEDICAL.

4. THUNDERBIRD (TBIRD.AS)

-8.28% Price Change

Thunderbird Resorts, Inc., through its subsidiaries, engages in the gaming, hospitality, and real estate businesses in Nicaragua and Peru. It provides table and slot games, and sportsbooks. The company operates 3 slot parlors, 3 casinos, and 630 gaming positions. It develops, owns, and operates real estate properties; and rents office spaces. The company was formerly known as International Thunderbird Gaming Corporation and changed its name to Thunderbird Resorts, Inc. in July 2005. Thunderbird Resorts, Inc. was incorporated in 1987 and is headquartered in Panama, the Republic of Panama.

AEX-Index ended the session with THUNDERBIRD sliding 8.28% to €0.07 on Thursday while AEX-Index jumped 0.03% to €787.04.

Earnings Per Share

As for profitability, THUNDERBIRD has a trailing twelve months EPS of €0.02.

PE Ratio

THUNDERBIRD has a trailing twelve months price to earnings ratio of 3.6. Meaning, the purchaser of the share is investing €3.6 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1297.11%.

More news about THUNDERBIRD.

5. KEYWARE TECH. (KEYW.BR)

-5.76% Price Change

Keyware Technologies NV, an independent fintech company, provides electronic payment solutions in Belgium. It offers payment transaction software for banks and financial institutions, tokenization software, instalment payment solutions, and ordering and payment app software; and payment processing and management services, as well as rents and sells payment terminals. The company was incorporated in 1996 and is headquartered in Zaventem, Belgium.

BEL 20 ended the session with KEYWARE TECH. dropping 5.76% to €0.90 on Thursday while BEL 20 slid 0.19% to €3,703.95.

Earnings Per Share

As for profitability, KEYWARE TECH. has a trailing twelve months EPS of €0.05.

PE Ratio

KEYWARE TECH. has a trailing twelve months price to earnings ratio of 18. Meaning, the purchaser of the share is investing €18 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.71%.

Yearly Top and Bottom Value

KEYWARE TECH.’s stock is valued at €0.90 at 21:40 EST, way below its 52-week high of €1.09 and way higher than its 52-week low of €0.81.

Volume

Today’s last reported volume for KEYWARE TECH. is 20 which is 99.5% below its average volume of 4023.

Volatility

KEYWARE TECH.’s last week, last month’s, and last quarter’s current intraday variation average was 1.35%, 0.35%, and 3.04%.

KEYWARE TECH.’s highest amplitude of average volatility was 1.89% (last week), 2.78% (last month), and 3.04% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, KEYWARE TECH.’s stock is considered to be oversold (<=20).

More news about KEYWARE TECH..

6. ATLANTIC SAPPHIRE (ASA.OL)

-5.45% Price Change

Atlantic Sapphire ASA, together with its subsidiaries, engages in the land-based salmon farming business. It operates through two segments, Fish Farming (Denmark); and Fish Farming (US). The company is involved in the production and sale of salmon. It operates in the United States, Denmark, and internationally. The company was founded in 2010 and is headquartered in Vikebukt, Norway.

Oslo Børs Benchmark Index_GI ended the session with ATLANTIC SAPPHIRE falling 5.45% to €1.63 on Thursday while Oslo Børs Benchmark Index_GI slid 0.21% to €1,304.40.

Earnings Per Share

As for profitability, ATLANTIC SAPPHIRE has a trailing twelve months EPS of kr-4.97.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 55.3%, now sitting on 18.95M for the twelve trailing months.

Volume

Today’s last reported volume for ATLANTIC SAPPHIRE is 2783080 which is 51.3% above its average volume of 1839440.

Moving Average

ATLANTIC SAPPHIRE’s worth is way below its 50-day moving average of kr6.29 and way below its 200-day moving average of kr6.74.

More news about ATLANTIC SAPPHIRE.

7. NORTHERN DRILLING (NODL.OL)

-4.98% Price Change

Northern Drilling Ltd. operates as an offshore drilling contractor to the oil and gas industry. The company primarily engages in acquiring and operating offshore drilling assets, as well as involved in drilling in ultra-deep water environments. Northern Drilling Ltd. was incorporated in 2017 and is based in Hamilton, Bermuda.

Oslo Børs Benchmark Index_GI ended the session with NORTHERN DRILLING falling 4.98% to €1.05 on Thursday while Oslo Børs Benchmark Index_GI slid 0.21% to €1,304.40.

Earnings Per Share

As for profitability, NORTHERN DRILLING has a trailing twelve months EPS of kr-5.73.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.22%.

Yearly Top and Bottom Value

NORTHERN DRILLING’s stock is valued at kr1.05 at 21:40 EST, way under its 52-week high of kr34.90 and way above its 52-week low of kr0.31.

Moving Average

NORTHERN DRILLING’s worth is way below its 50-day moving average of kr1.97 and way under its 200-day moving average of kr19.60.

More news about NORTHERN DRILLING.

8. POXEL (POXEL.PA)

-4.84% Price Change

Poxel S.A., a clinical-stage biopharmaceutical company, develops novel treatments for metabolic diseases, type 2 diabetes, and liver diseases. The company's lead product is TWYMEEG (Imeglimin), an oral drug candidate that targets mitochondrial dysfunction and approved for the treatment of type 2 diabetes in Japan. It also develops PXL770, an adenosine monophosphate-activated protein kinase enzyme, which is in a Phase 2a clinical trial that treats chronic metabolic diseases, including diseases that affect the liver, such as non-alcoholic steatohepatitis (NASH); PXL065, an earlier stage programs that is in Phase 2 for the treatment of NASH focusing on chronic and rare metabolic indications. The company has a licensing agreement with Enyo Pharma S.A.S. for the development of farnesoid X receptor that is in Phase 2a study for the treatment of hepatitis B and NASH; and DeuteRx LLC for the development of PXL065, a mitochondrial pyruvate carrier inhibitor, which is in a phase I clinical trial for the treatment of NASH. Poxel S.A. was incorporated in 2009 and is headquartered in Lyon, France.

CAC 40 ended the session with POXEL sliding 4.84% to €0.61 on Thursday while CAC 40 slid 0.48% to €7,535.16.

Earnings Per Share

As for profitability, POXEL has a trailing twelve months EPS of €-1.08.

Yearly Top and Bottom Value

POXEL’s stock is valued at €0.61 at 21:40 EST, way under its 52-week high of €1.08 and way above its 52-week low of €0.30.

Volatility

POXEL’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.87%, a positive 5.23%, and a positive 3.94%.

POXEL’s highest amplitude of average volatility was 11.21% (last week), 9.32% (last month), and 3.94% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, POXEL’s stock is considered to be oversold (<=20).

Volume

Today’s last reported volume for POXEL is 304859 which is 94.09% above its average volume of 157066.

More news about POXEL.

9. HAVILA SHIPPING (HAVI.OL)

-4.12% Price Change

Havila Shipping ASA, together with its subsidiaries, engages in the shipping business. It manages and operates offshore service vessels primarily in Norway, the United Kingdom, Denmark, Belgium, the Netherlands, Iceland, Tunisia, the Marshall Islands, and the United States. The company operates a fleet of 17 vessels, including 2 anchor handling vessels, 11 platform supply vessels, 1 rescue recovery vessel, and 3 subsea vessels. Its anchor handling tug and supply vessels are used for moving rigs and putting out anchors, as well as for supply services; platform supply vessels are used to carry goods, water, drilling mud, chemicals, etc. to and from the offshore installations; subsea vessels are used for under water construction work, as well as for support for under water operations; and rescue recovery vessels are used to offer security services, such as oil spill preparedness, fire protection, rescue operation, and recovery at oil installations. The company was founded in 2003 and is headquartered in Fosnavåg, Norway. Havila Shipping ASA is a subsidiary of Havila Holding AS.

Oslo Børs Benchmark Index_GI ended the session with HAVILA SHIPPING falling 4.12% to €5.35 on Thursday, following the last session’s upward trend. Oslo Børs Benchmark Index_GI dropped 0.21% to €1,304.40, after two consecutive sessions in a row of gains, on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, HAVILA SHIPPING has a trailing twelve months EPS of kr-2.45.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 345.66%.

Volatility

HAVILA SHIPPING’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.38%, a positive 0.53%, and a positive 3.88%.

HAVILA SHIPPING’s highest amplitude of average volatility was 4.29% (last week), 4.22% (last month), and 3.88% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, HAVILA SHIPPING’s stock is considered to be oversold (<=20).

Earnings Before Interest, Taxes, Depreciation, and Amortization

HAVILA SHIPPING’s EBITDA is 2.4.

Moving Average

HAVILA SHIPPING’s worth is way below its 50-day moving average of kr6.87 and way under its 200-day moving average of kr11.24.

More news about HAVILA SHIPPING.

10. ARRIBATEC GROUP (ARR.OL)

-4.01% Price Change

Arribatec Group ASA, a software and consulting company, provides digital business solutions in Norway, Europe, the Americas, and internationally. The company offers solutions for businesses, including ERP systems, integrations, consulting, health checks, develops, HR and payroll, financial and project planning, bank solutions, and travel and expenses. Its solutions include QualiWare, a management system that structures and visualizes processes, activities, regulations, and requirements; Unit4 solutions; RamBase, an ERP business solution that gives control over the value chain; Power BI solutions; Hypergene, a business management tool; Adra Suite that integrates with other financial systems; Microsoft 365; CatalystOne; and Pagero that ensures compliance with legal and electronic billing requirements. The company was incorporated in 1998 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with ARRIBATEC GROUP sliding 4.01% to €4.55 on Thursday while Oslo Børs Benchmark Index_GI slid 0.21% to €1,304.40.

Earnings Per Share

As for profitability, ARRIBATEC GROUP has a trailing twelve months EPS of kr-1.39.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.94%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 23.2%, now sitting on 557M for the twelve trailing months.

More news about ARRIBATEC GROUP.

Stay up to date with our winners and losers daily report